The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Standard
The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer. / Vashist, Yogesh; Kutup, Asad; Musici, Safije; Yekebas, Emre F.; Mina, Sormeh; Uzunoglu, Faik Güntac; Zehler, Oliver; König, Alexandra; Cataldegirmen, Güllü; Bockhorn, Maximilian; Harms-Effenberger, Katharina; Kalinin, Vjacheslav; Pantel, Klaus; Izbicki, Jakob R.
in: MOL CELL ONCOL, Jahrgang 34, Nr. 4, 4, 2011, S. 281-288.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
AU - Vashist, Yogesh
AU - Kutup, Asad
AU - Musici, Safije
AU - Yekebas, Emre F.
AU - Mina, Sormeh
AU - Uzunoglu, Faik Güntac
AU - Zehler, Oliver
AU - König, Alexandra
AU - Cataldegirmen, Güllü
AU - Bockhorn, Maximilian
AU - Harms-Effenberger, Katharina
AU - Kalinin, Vjacheslav
AU - Pantel, Klaus
AU - Izbicki, Jakob R.
PY - 2011
Y1 - 2011
N2 - Genetic variations in cancer patients may serve as important prognostic indicators of clinical outcome. The GNAS1 T393C single nucleotide polymorphism (SNP) diversely correlates with the clinical outcome in cancer. The aim of this study was to evaluate the potential prognostic value of T393C-SNP in complete resected only surgically treated esophageal cancer (EC).
AB - Genetic variations in cancer patients may serve as important prognostic indicators of clinical outcome. The GNAS1 T393C single nucleotide polymorphism (SNP) diversely correlates with the clinical outcome in cancer. The aim of this study was to evaluate the potential prognostic value of T393C-SNP in complete resected only surgically treated esophageal cancer (EC).
U2 - 10.1007/s13402-011-0016-x
DO - 10.1007/s13402-011-0016-x
M3 - SCORING: Journal article
VL - 34
SP - 281
EP - 288
JO - MOL CELL ONCOL
JF - MOL CELL ONCOL
SN - 2372-3556
IS - 4
M1 - 4
ER -